Baraibar, I., Morabito, S., Nieto, J., Deuner, G., Melero, J. L., Salva, F., Grzelak, M., Montañá, J. R., Caratu, G., Perez-Lopez, R., Nieto, P., Rotem, A., Casbas-Hernandez, P., Martinez-Martin, N., Gros, A., Tabernero, J., Elez, E. (2026). The SERPENTINE trial: A phase II clinical study decoding immune responses by scRNA-seq and TCR-seq analysis in patients with MSS metastatic colorectal cancer (mCRC) with and without liver metastases treated with durvalumab and tremelimumab.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.3607